Discovery of meisoindigo derivatives as noncovalent and orally available Mpro inhibitors: their therapeutic implications in the treatment of COVID-19
-
Published:2024-07
Issue:
Volume:273
Page:116498
-
ISSN:0223-5234
-
Container-title:European Journal of Medicinal Chemistry
-
language:en
-
Short-container-title:European Journal of Medicinal Chemistry
Author:
Gao Qingtian,
Liu Sixu,
Zhou Yuzheng,
Fan Jinbao,
Ke Shufen,
Zhou Yuqing,
Fan Kaiqiang,
Wang Yuxuan,
Zhou Yingjun,
Xia Zanxian,
Deng XuORCID